CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 106 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $36,000 | -7.7% | 12,908 | +0.3% | 0.00% | – |
| Q4 2020 | $39,000 | -51.9% | 12,874 | -2.8% | 0.00% | – |
| Q3 2020 | $81,000 | +1.2% | 13,244 | -2.2% | 0.00% | – |
| Q2 2020 | $80,000 | +116.2% | 13,545 | -3.1% | 0.00% | – |
| Q1 2020 | $37,000 | -7.5% | 13,978 | -5.5% | 0.00% | – |
| Q4 2019 | $40,000 | -77.9% | 14,786 | -0.8% | 0.00% | -100.0% |
| Q3 2019 | $181,000 | +5.2% | 14,910 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $172,000 | – | 15,015 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MFN Partners Management, LP | 1,487,874 | $17,036,000 | 2.70% |
| BRIDGER MANAGEMENT, LLC | 1,032,633 | $11,824,000 | 0.93% |
| EcoR1 Capital, LLC | 776,206 | $8,888,000 | 0.90% |
| Camber Capital Management LP | 1,561,915 | $17,884,000 | 0.83% |
| CVI Holdings, LLC | 157,114 | $1,798,000 | 0.70% |
| Artal Group S.A. | 1,361,584 | $15,590,000 | 0.63% |
| Slate Path Capital LP | 714,018 | $8,176,000 | 0.37% |
| Sarissa Capital Management LP | 250,000 | $2,862,000 | 0.36% |
| AWH Capital, L.P. | 10,107 | $116,000 | 0.17% |
| Broderick Brian C | 32,919 | $377,000 | 0.13% |